Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.
Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U; Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) Study Investigators. Fearon WF, et al. Among authors: bornschein b. Circulation. 2010 Dec 14;122(24):2545-50. doi: 10.1161/CIRCULATIONAHA.109.925396. Epub 2010 Nov 29. Circulation. 2010. PMID: 21126973 Clinical Trial.
Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI.
Siebert U, Arvandi M, Gothe RM, Bornschein B, Eccleston D, Walters DL, Rankin J, De Bruyne B, Fearon WF, Pijls NH, Harper R. Siebert U, et al. Among authors: bornschein b. Heart Lung Circ. 2014 Jun;23(6):527-33. doi: 10.1016/j.hlc.2013.12.009. Epub 2014 Jan 22. Heart Lung Circ. 2014. PMID: 24560401 Clinical Trial.
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B; FAME Study Investigators. Pijls NH, et al. Among authors: bornschein b. J Am Coll Cardiol. 2010 Jul 13;56(3):177-84. doi: 10.1016/j.jacc.2010.04.012. Epub 2010 May 28. J Am Coll Cardiol. 2010. PMID: 20537493 Free article. Clinical Trial.
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.
Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R. Dams J, et al. Among authors: bornschein b. Health Qual Life Outcomes. 2013 Mar 8;11:35. doi: 10.1186/1477-7525-11-35. Health Qual Life Outcomes. 2013. PMID: 23497005 Free PMC article.
Cost of illness and its predictors for Parkinson's disease in Germany.
Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R. Spottke AE, et al. Among authors: bornschein b. Pharmacoeconomics. 2005;23(8):817-36. doi: 10.2165/00019053-200523080-00007. Pharmacoeconomics. 2005. PMID: 16097843
28 results